Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Cash Flows From Operating Activities | |||||
Net Income | 7,941,000 | 3,255,000 | 35,153,000 | 31,104,000 | 5,076,000 |
Depreciation Amortization | 3,597,000 | 1,815,000 | 7,486,000 | 5,643,000 | 3,814,000 |
Income taxes - deferred | -2,257,000 | -1,562,000 | -4,194,000 | -1,782,000 | -2,342,000 |
Accounts receivable | -1,163,000 | -279,000 | -624,000 | -851,000 | -599,000 |
Other Working Capital | -790,000 | -338,000 | 2,507,000 | -740,000 | -138,000 |
Other Operating Activity | 1,962,000 | 766,000 | -17,537,000 | -18,446,000 | 1,628,000 |
Operating Cash Flow | $9,290,000 | $3,657,000 | $22,791,000 | $14,928,000 | $7,439,000 |
Cash Flows From Investing Activities | |||||
PPE Investments | -1,210,000 | -597,000 | -4,185,000 | -2,717,000 | -1,871,000 |
Net Acquisitions | -14,807,000 | -1,811,000 | N/A | N/A | N/A |
Purchase Of Investment | -1,184,000 | -630,000 | -10,906,000 | -9,981,000 | -9,688,000 |
Sale Of Investment | 1,706,000 | 979,000 | 19,390,000 | 15,787,000 | 11,877,000 |
Other Investing Activity | 1,344,000 | 1,595,000 | -3,421,000 | -1,009,000 | -779,000 |
Investing Cash Flow | $-14,151,000 | $-464,000 | $878,000 | $2,080,000 | $-461,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 13,976,000 | 5,263,000 | 21,790,000 | 20,509,000 | 12,221,000 |
Debt Issued | 6,659,000 | 2,000 | N/A | N/A | 7,674,000 |
Debt Repayment | -803,000 | -1,000 | -1,551,000 | -502,000 | -501,000 |
Common Stock Issued | 290,000 | 195,000 | 5,335,000 | 5,148,000 | 4,495,000 |
Common Stock Repurchased | -1,611,000 | -1,475,000 | -5,054,000 | -4,838,000 | -3,918,000 |
Dividend Paid | -5,854,000 | -2,869,000 | -11,770,000 | -8,905,000 | -6,034,000 |
Other Financing Activity | -4,567,000 | -569,000 | -24,575,000 | -22,582,000 | -13,790,000 |
Financing Cash Flow | $8,090,000 | $546,000 | $-15,825,000 | $-11,170,000 | $147,000 |
Exchange Rate Effect | -210,000 | -125,000 | -112,000 | -237,000 | -69,000 |
Beginning Cash Position | 21,859,000 | 21,859,000 | 14,127,000 | 14,127,000 | 14,127,000 |
End Cash Position | 24,878,000 | 25,473,000 | 21,859,000 | 19,728,000 | 21,183,000 |
Net Cash Flow | $3,019,000 | $3,614,000 | $7,732,000 | $5,601,000 | $7,056,000 |
Free Cash Flow | |||||
Operating Cash Flow | 9,290,000 | 3,657,000 | 22,791,000 | 14,928,000 | 7,439,000 |
Capital Expenditure | -1,783,000 | -807,000 | -4,543,000 | -2,954,000 | -1,987,000 |
Free Cash Flow | 7,507,000 | 2,850,000 | 18,248,000 | 11,974,000 | 5,452,000 |